ONC213
Live / Allowed — Fourth extension granted (statement of use) (as of 23 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Sept 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98171928
- Mark type
- Word mark
- Filed
- 08 Sept 2023
- Published for opposition
- 13 Aug 2024
- Attorney of record
- Michael T. Olsen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for use in the treatment of oncological and neurological diseases and disorders
Owner
- Chimerix, Inc., Durham, NC, US
- Chimerix, Inc., Durham, NC, US
Prosecution history
- 26 Oct 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Oct 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Oct 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Sept 2026 — SOU EXTENSION 4 GRANTED
- 23 Sept 2026 — SOU EXTENSION 4 FILED
- 23 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2026 — SOU EXTENSION 3 GRANTED
- 02 Apr 2026 — SOU EXTENSION 3 FILED
- 02 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2025 — SOU EXTENSION 2 GRANTED
- 04 Aug 2025 — SOU EXTENSION 2 FILED
- 04 Aug 2025 — SOU TEAS EXTENSION RECEIVED